Suchergebnisse - (Person:"Rizk, John G")

PubPharm (43)

31

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

enthalten in: Reviews in endocrine & metabolic disorders | 2021

von Rizk, J. | Lazo, J. | Quan, D. | +5

32

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

enthalten in: Reviews in endocrine & metabolic disorders | 2021

von Rizk, J. | Lazo, J. | Quan, D. | +5

33

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

enthalten in: Reviews in endocrine & metabolic disorders | 2021

von Rizk, J. | Lazo, J. | Quan, D. | +5

34

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic

enthalten in: Drug discovery today | 2021

von Rizk, J. | Forthal, D. | Kalantar-Zadeh, K. | +5

35

Low-dose aspirin for early COVID-19: does the early bird catch the worm?

enthalten in: Expert opinion on investigational drugs | 2021

von Rizk, J. | Lavie, C. | Gupta, A.

36

Pharmaco-Immunomodulatory Therapy in COVID-19

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3

CommentIn: Drugs. 2020 Sep;80(14):1499-1500. - PMID 32880807

37

Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3

CommentOn: Drugs. 2020 Sep;80(14):1499-1500. - PMID 32880807

38

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3

39

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3

40

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3